These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 22639321)

  • 1. [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
    Baylan O
    Mikrobiyol Bul; 2012 Apr; 46(2):304-18. PubMed ID: 22639321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burkholderia cepacia complex: beyond pseudomonas and acinetobacter.
    Gautam V; Singhal L; Ray P
    Indian J Med Microbiol; 2011; 29(1):4-12. PubMed ID: 21304187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of commercial systems VITEK 2 and API 20NE for identification of Burkholderia cepacia complex bacteria from clinical samples].
    Oderiz S; Palau MJ; Del Palacio P; Lewis MC; Bettiol MP; Martina P; Bosch A; Yantorno OM; Gatti BM
    Rev Argent Microbiol; 2011; 43(3):168-75. PubMed ID: 22430988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.
    Mahenthiralingam E; Baldwin A; Dowson CG
    J Appl Microbiol; 2008 Jun; 104(6):1539-51. PubMed ID: 18217926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
    Drevinek P; Mahenthiralingam E
    Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multifarious, multireplicon Burkholderia cepacia complex.
    Mahenthiralingam E; Urban TA; Goldberg JB
    Nat Rev Microbiol; 2005 Feb; 3(2):144-56. PubMed ID: 15643431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species.
    Leitão JH; Sousa SA; Ferreira AS; Ramos CG; Silva IN; Moreira LM
    Appl Microbiol Biotechnol; 2010 Jun; 87(1):31-40. PubMed ID: 20390415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
    Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation and identification of Burkholderia cepacia complex from cystic fibrosis patients].
    Yurdakul P; Ergünay K; Yalçin E; Doğru D; Sener B; Cobanoğlu N; Ozçelik U; Kiper N
    Mikrobiyol Bul; 2006 Oct; 40(4):301-6. PubMed ID: 17205687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia cepacia complex infections: More complex than the bacterium name suggest.
    Sfeir MM
    J Infect; 2018 Sep; 77(3):166-170. PubMed ID: 30012345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.
    Henry DA; Campbell ME; LiPuma JJ; Speert DP
    J Clin Microbiol; 1997 Mar; 35(3):614-9. PubMed ID: 9041399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxonomy and pathogenesis of the Burkholderia cepacia complex.
    Mahenthiralingam E; Vandamme P
    Chron Respir Dis; 2005; 2(4):209-17. PubMed ID: 16541604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis.
    Porter LA; Goldberg JB
    Front Cell Infect Microbiol; 2011; 1():9. PubMed ID: 22919575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkholderia cepacia: medical, taxonomic and ecological issues.
    Govan JR; Hughes JE; Vandamme P
    J Med Microbiol; 1996 Dec; 45(6):395-407. PubMed ID: 8958242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis.
    Henry D; Campbell M; McGimpsey C; Clarke A; Louden L; Burns JL; Roe MH; Vandamme P; Speert D
    J Clin Microbiol; 1999 Apr; 37(4):1004-7. PubMed ID: 10074517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Burkholderia cepacia: a new pathogen causing nosocomial infections].
    Lipowski D; Rzadkiewicz E; Czekalska-Lachowicz E
    Przegl Epidemiol; 2008; 62(1):7-17. PubMed ID: 18536220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.
    Segonds C; Clavel-Batut P; Thouverez M; Grenet D; Le Coustumier A; Plésiat P; Chabanon G
    J Clin Microbiol; 2009 May; 47(5):1510-6. PubMed ID: 19297595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis].
    Segonds C; Chabanon G
    Ann Biol Clin (Paris); 2001; 59(3):259-69. PubMed ID: 11397673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
    St Denis M; Ramotar K; Vandemheen K; Tullis E; Ferris W; Chan F; Lee C; Slinger R; Aaron SD
    Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.